GSC
SGTX

Ground Swell Capital’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History

Ground Swell Capital’s Portfolio SGTX Stock Details SGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,972
Closed -$23.8K – 103
2023
Q1 		$23.8K Buy
+1,972
New +$23.8K 0.04% 38